<html lang="en">
    <head>
        <meta charset="UTF-8">
        <meta name="viewport" content="width=device-width, initial-scale=1.0">
        <link rel="shortcut icon" type="image/x-icon" href="assets/favicon.ico">
        <link rel="stylesheet" href="styles.css">
        <title>ASBL - The Matrix Dex</title>
    </head>
    <body>
    <br>
    <h1>ASBL</h1>
    <br>
    <p>Automated Synthetic Biology Labs</p><p>ASBL makes robotic labs for hands-free experiments. Ditch the gloves, be a keyboard bioengineer.</p><p>Contact: <a href='mailto:manonthemoon13131@gmail.com'>manonthemoon13131@gmail.com</a></p><p>Products in ASBL:</p><p>1. ASBL Lab 0 ($500,000): automated cell feeder<br>This machine feeds bacterial and mammalian cells to keep cells alive. ASBL Lab 0 integrates a liquid handler, plate reader, incubator, refrigerator, cell counter, and robotic arm. Use with Python.</p><p>2. ASBL 1 ($1 million): automated bacterial genetic engineer<br>This machine genetically engineers E. coli K12 cells. ASBL Lab 0 + template plasmid synthesis + purification + transformation integrations. This machine outputs a genetically engineered bacterial colony given an input plasmid. Use with Python.</p><p>3. ASBL II ($10 million): automated mammalian genetic engineer<br>Lipid nanoparticle mRNA transfection expressed in 96 wells per cycle. Use with Python.</p><p>Software:</p><p>4. <a href='https://github.com/matrixdex/diabetessubtype'>HumanGEMlib</a> is a Python library for human genome-scale modeling. <a href='https://github.com/SysBioChalmers/Human-GEM'>HumanGEM</a> (<a href='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7331181/'>1</a>) comprehensive human reaction network, and <a href='https://cobrapy.readthedocs.io/en/latest/index.html'>COBRApy</a> (flux balance analysis) power HumanGEMlib to simulate effects of genetic knockouts on human metabolism. Type 2 diabetes signature metabolisms reported <a href='https://github.com/alinoorul/reports/blob/main/diabetes%20systems%20biology.pdf'>here</a>.</p><p>Drug pipeline:</p><p>5. Mohsina (preclinical): insulin replacement for insulin-resistant type 2 diabetes. Messenger RNA (mRNA) and antisense oligonucleotide (ASO) combinations combat metabolic dysregulation.</p><p>6. MID (preclinical): insulin replacement for insulin-deficient type 2 diabetes</p><p>Projects in ASBL:</p><p>7. <a href='matrixims.html'>Matrixims</a>: brain organoids (<a href='https://doi.org/10.1016/j.neuron.2022.09.001'>3</a>) playing <a href='https://en.wikipedia.org/wiki/The_Sims_(video_game)'>The Sims</a></p><p>8. Deconstructed human: organoid (<a href='https://doi.org/10.1126/sciadv.aaw2459'>4</a>,<a href='https://doi.org/10.1038/s41592-019-0325-y'>5</a>) bioreactors for testing</p><p>9. Protein laser conjugated with quantum dot</p><p>10. Cellular agriculture of wasabi and truffles</p><p>11. ASBL 4: automated meat printer</p><p>12. Microtubules in carbon nanotube applications</p><p>13. Small molecule targeted delivery</p><p>ASBL INC. is incorporated in Delaware, United States.</p><p>Cap table<br><a href='https://www.linkedin.com/in/noorulali'>Noorul Ali</a>&emsp;100%</p>
    <br><br><br><br><br><br><br>
    <h3><a href="index.html">THE MATRIX</a></h3>
</body>
</html>